接种 COVID-19 疫苗后出现的类狼疮样皮肤反应。
Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
机构信息
Department of Dermatology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
出版信息
J Cutan Pathol. 2022 Nov;49(11):943-946. doi: 10.1111/cup.14281. Epub 2022 Aug 4.
Abstract
Multiple adverse cutaneous reactions have been described following vaccination against COVID-19. This case report describes a reaction to the Pfizer-BioNTech (BNT162b2) vaccine that histopathologically resembles cutaneous lupus erythematosus with vacuolar interface alteration, superficial to mid-dermal perivascular and periadnexal lymphocytic infiltrate with clusters of CD123 cells, and mildly increased dermal mucin.
摘要
接种 COVID-19 疫苗后出现了多种不良反应。本病例报告描述了一例对辉瑞-生物科技（BNT162b2）疫苗的反应，其组织病理学表现类似于具有空泡界面改变的红斑狼疮，真皮浅层至中层血管周围和附属器周围淋巴细胞浸润，伴有 CD123 细胞簇，真皮粘蛋白轻度增加。
相似文献
1
Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.接种 COVID-19 疫苗后出现的类狼疮样皮肤反应。
J Cutan Pathol. 2022 Nov;49(11):943-946. doi: 10.1111/cup.14281. Epub 2022 Aug 4.
2
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.基于mRNA或腺病毒载体的SARS-CoV-2疫苗接种后亚急性皮肤型红斑狼疮的诱发和加重
Clin Exp Dermatol. 2022 Jan;47(1):161-163. doi: 10.1111/ced.14858. Epub 2021 Sep 13.
3
Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine.辉瑞/生物科技公司 COVID-19 疫苗接种后的皮肤不良反应。
Australas J Dermatol. 2022 Aug;63(3):e247-e250. doi: 10.1111/ajd.13859. Epub 2022 May 23.
4
New-onset cutaneous lupus erythematosus after the COVID-19 vaccine.接种新冠疫苗后出现新发盘状红斑狼疮。
Dermatol Online J. 2021 Nov 15;27(11). doi: 10.5070/D3271156093.
5
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后亚急性皮肤型红斑狼疮病情加重
Dermatol Ther. 2021 Jul;34(4):e15017. doi: 10.1111/dth.15017. Epub 2021 Jun 8.
6
Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.辉瑞新冠疫苗诱发的亚急性皮肤型红斑狼疮
Ital J Dermatol Venerol. 2023 Jun;158(3):266-267. doi: 10.23736/S2784-8671.23.07373-5. Epub 2023 Mar 7.
7
Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review.COVID-19 疫苗接种后出现急性胰腺炎和血管炎性皮疹的系统性红斑狼疮：病例报告及文献复习。
Clin Rheumatol. 2022 May;41(5):1577-1582. doi: 10.1007/s10067-022-06097-z. Epub 2022 Feb 17.
8
New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review.接种 BNT162b2 mRNA COVID-19 疫苗后新发系统性红斑狼疮：病例系列及文献复习。
Rheumatol Int. 2022 Dec;42(12):2261-2266. doi: 10.1007/s00296-022-05203-3. Epub 2022 Sep 13.
9
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al.新型冠状病毒肺炎疫苗接种后的皮肤不良反应：来自意大利南部转诊中心的报告。对Luo等人《辉瑞/生物新技术公司新型冠状病毒肺炎疫苗接种后的皮肤不良反应》的评论
Australas J Dermatol. 2023 Feb;64(1):e103-e105. doi: 10.1111/ajd.13984. Epub 2023 Jan 22.
10
Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.首次接种辉瑞-生物科技（BNT162b2）疫苗（即 Pfizer-BioNTech，也被称为复必泰）后出现中毒性表皮坏死松解症，同时进行药物基因组学检测。
Pediatr Dermatol. 2022 Jul;39(4):601-605. doi: 10.1111/pde.15074.
引用本文的文献
1
Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy.抗SARS-CoV-2疫苗皮肤不良反应的组织病理学模式：皮肤活检的综合作用
Vaccines (Basel). 2023 Feb 9;11(2):397. doi: 10.3390/vaccines11020397.
2
A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与自身免疫性疾病的综述：有何关联？
Life (Basel). 2022 Nov 18;12(11):1918. doi: 10.3390/life12111918.
Zotero 插件